|
|
|
Insider
Information: |
Gonella Jacques |
Relationship: |
Director |
City: |
Exton |
State: |
PA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
9,385,848 |
|
Indirect Shares
|
2,900,000 |
|
|
Direct
Value |
$52,466,890 |
|
|
Indirect Value
|
$16,211,000 |
|
|
Total
Shares |
12,285,848 |
|
|
Total
Value |
$68,677,890 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Antares Pharma Inc |
ATRS |
Director |
2019-02-26 |
9,385,848 |
2008-06-04 |
2,900,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ATRS |
Antares Pharma Inc |
Director |
|
2018-05-30 |
4 |
S |
$2.55 |
$255,000 |
D/D |
(100,000) |
10,865,351 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2018-05-23 |
4 |
S |
$2.50 |
$489,545 |
D/D |
(194,682) |
10,965,351 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2018-05-22 |
4 |
S |
$2.53 |
$13,455 |
D/D |
(5,318) |
11,160,033 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2018-05-18 |
4 |
S |
$2.60 |
$54,761 |
D/D |
(21,062) |
11,165,351 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2018-05-17 |
4 |
S |
$2.55 |
$255,000 |
D/D |
(100,000) |
11,186,413 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2018-05-16 |
4 |
S |
$2.52 |
$252,000 |
D/D |
(100,000) |
11,286,413 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2018-05-15 |
4 |
S |
$2.50 |
$250,000 |
D/D |
(100,000) |
11,386,413 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2018-05-14 |
4 |
S |
$2.50 |
$250,000 |
D/D |
(100,000) |
11,486,413 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2018-05-11 |
4 |
S |
$2.47 |
$247,000 |
D/D |
(100,000) |
11,586,413 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2018-05-10 |
4 |
S |
$2.36 |
$236,000 |
D/D |
(100,000) |
11,686,413 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2018-05-09 |
4 |
AS |
$2.46 |
$740,400 |
D/D |
(300,000) |
11,786,413 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2016-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,900,000 |
12,026,413 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2017-03-31 |
4 |
OE |
$1.65 |
$49,500 |
D/D |
30,000 |
12,056,413 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2018-05-03 |
4 |
OE |
$0.85 |
$25,500 |
D/D |
30,000 |
12,086,413 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2004-08-20 |
4 |
B |
$1.07 |
$107,000 |
D/D |
100,000 |
12,587,497 |
3.92 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2004-08-24 |
4 |
B |
$1.01 |
$101,000 |
D/D |
100,000 |
12,799,497 |
3.92 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2004-08-25 |
4 |
B |
$1.00 |
$125,000 |
D/D |
125,000 |
12,924,497 |
3.92 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2004-08-27 |
4 |
B |
$1.18 |
$12,980 |
D/D |
11,000 |
12,935,497 |
3.92 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2004-05-25 |
4 |
A |
$0.96 |
$96,000 |
I/I |
100,000 |
12,942,497 |
|
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2004-08-30 |
4 |
B |
$1.23 |
$98,400 |
D/D |
80,000 |
13,515,497 |
3.92 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2005-03-31 |
4 |
A |
$0.98 |
$63,700 |
D/D |
65,000 |
13,615,060 |
|
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2005-03-31 |
4 |
A |
$1.06 |
$35,722 |
D/D |
33,700 |
13,648,760 |
|
- |
|
47 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|